Clinical Trials Browser

Phase 1 × Terminated × Monatide (IMS 3015) × Clear all

NCT01810016 2022-10-12

NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Phase 1 Terminated

8 enrolled 16 charts

Melanoma, Neoplasms

NCT02452775 2020-04-24

Autologous OC-L Vaccine and Ovarian Cancer

Phase 1 Terminated

Fallopian Tube Neoplasms